Pre-eclampsia: pathogenesis, novel diagnostics and therapies

EA Phipps, R Thadhani, T Benzing… - Nature Reviews …, 2019‏ - nature.com
Pre-eclampsia is a complication of pregnancy that is associated with substantial maternal
and fetal morbidity and mortality. The disease presents with new-onset hypertension and …

[HTML][HTML] Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders

S Rana, SD Burke, SA Karumanchi - American journal of obstetrics and …, 2022‏ - Elsevier
Preeclampsia is a devastating medical complication of pregnancy that can lead to significant
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …

Pre‐eclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study

M Mendoza, I Garcia‐Ruiz, N Maiz… - … Journal of Obstetrics …, 2020‏ - Wiley Online Library
Objectives To investigate the incidence of clinical, ultrasonographic and biochemical
findings related to pre‐eclampsia (PE) in pregnancies with COVID‐19, and to assess their …

Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia

H Zeisler, E Llurba, F Chantraine… - … England Journal of …, 2016‏ - Mass Medical Soc
Background The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor
(PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its …

Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 …

J Sheikh, J Allotey, T Kew, BM Fernández-Félix… - The Lancet, 2022‏ - thelancet.com
Background Existing evidence on the effects of race and ethnicity on pregnancy outcomes is
restricted to individual studies done within specific countries and health systems. We aimed …

Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome

H Stepan, M Hund, T Andraczek - Hypertension, 2020‏ - ahajournals.org
Placental dysfunction underlies a spectrum of perinatal pathologies, including preeclampsia
and fetal growth restriction. Angiogenesis-related factors, including sFlt-1 (soluble fms-like …

The competing risk approach for prediction of preeclampsia

D Wright, A Wright, KH Nicolaides - American journal of obstetrics and …, 2020‏ - Elsevier
The established method of the assessment of the risk for development of preeclampsia is to
identify risk factors from maternal demographic characteristics and medical history; in the …

Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study

LC Chappell, S Duckworth, PT Seed, M Griffin… - Circulation, 2013‏ - ahajournals.org
Background—Hypertensive disorders of pregnancy are a major contributor to death and
disability for pregnant women and their infants. The diagnosis of preeclampsia by using …

[HTML][HTML] Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach

RE Young, KM Nelson, SI Hofbauer, T Vijayakumar… - Bioactive Materials, 2024‏ - Elsevier
Ionizable lipid nanoparticles (LNPs) have gained attention as mRNA delivery platforms for
vaccination against COVID-19 and for protein replacement therapies. LNPs enhance mRNA …

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia: Compiled by the …

LC Poon, LA Magee, S Verlohren… - … of Gynecology & …, 2021‏ - Wiley Online Library
Pre-eclampsia is a multisystem disorder that typically affects 2%–5% of pregnant women
and is one of the leading causes of maternal and perinatal morbidity and mortality …